Buy Kisqali 200 MG (relabeled as Kryxana)

$986.00 USD

Kryxana® (relabeled Kisqali®) is used in combination with other drugs for the treatment of advanced or metastatic breast cancer whose cells are hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative (HER2-).

Package Size : 21 Tablets

Active Ingredient : Ribociclib 200 MG

Manufactured by Novartis AG®

Product of Singapore


SKU: 16062 Category: Tags: , ,